Fed. Circ. Upholds Endo's PTAB Win In Amneal Patent Fight
The Federal Circuit on Tuesday affirmed a Patent Trial and Appeal Board decision finding that prior art didn't make Endo Pharmaceuticals Inc.'s patents for the painkiller Opana ER obvious, rejecting Amneal...To view the full article, register now.
Already a subscriber? Click here to view full article